ASC30 tablets A1

DRUG2 trials

Sponsors

Ascletis Pharma (China) Co., Limited

Conditions

Chronic Weight ManagementObesityOverweightType 2 Diabetes Mellitus

Phase 3

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RecruitingNCT07743450

Ascletis Pharma (China) Co., LimitedChronic Weight Management, Obesity, Overweight +1

Start: 2026-08-28End: 2028-07-01Target: 1560Updated: 2026-09-16

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RecruitingNCT07743463

Ascletis Pharma (China) Co., LimitedChronic Weight Management, Obesity, Overweight

Start: 2026-08-31End: 2028-07-01Target: 3003Updated: 2026-09-16